<DOC>
	<DOCNO>NCT00182377</DOCNO>
	<brief_summary>Patients undergo cardiac surgery cardiopulmonary bypass require significant fluid administration . Fluids use routinely replace blood lose surgery . Significant amount fluid also use prime tube component cardiopulmonary bypass pump use . The use Pentaspan - synthetic pentastarch - start restriction use blood blood product , particularly albumin . Pentaspan usually use surgery Intensive Care Unit ( ICU ) . The impact use pentastarch coagulation , fluid balance bleeding limited . This study methodically evaluate impact use increasingly great amount pentastarch surgery open heart surgery patient 's recovery particular - bleeding , his/her blood clot well , much fluid overall use excrete ?</brief_summary>
	<brief_title>Pentastarch Use Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>All patient undergo either coronary artery bypass surgery valve surgery require use cardiopulmonary bypass circuit Emergency surgery Regurgitant valve pathology Redo surgery Significant leave ventricular ( LV ) dysfunction Significant renal insufficiency Anticipation associate procedure eg carotid endarterectomy Ongoing sepsis endocarditis Received aspirin ( ASA ) Plavix within 96 hour surgery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2004</verification_date>
	<keyword>patient undergo cardiac surgery require cardiopulmonary bypass</keyword>
</DOC>